Arcadia Biosciences Stock News

Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC ) shares jumped 138.1% to close at $1.50 on Thursday after dropping 37% on Wednesday. AgriFORCE Growing Systems, Ltd. (NASDAQ: AGRI ) gained 102.4% to close at $3.42 after the company announced a binding letter of intent to acquire Deroose Planta NV. Enservco Corporation (NYSE: ENSV ) shares jumped 43.1% to close at $4.32 after dropping 28% on Wednesday. Hoth Therapeutics, Inc. (NASDAQ: HOTH ) gained 38.8% to close at $0.7968 following circulation of an FDA AccessData.gov listing which showed the company''s c-KIT-targeting candidate received orphan-drug designation. AquaBounty Technologies, Inc. (NASDAQ: AQB ) surged 37.8% to close at $1.93 after the company reported FY21 EPS results were higher year over year. Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX ) jumped 33.4% to close at $0.50. Almaden Minerals Ltd. (NYSE: AAU ) gained 32.9% to settle at $0.4480. Ebix, Inc. (NASDAQ: EBIX ) jumped 31.4% to settle at $41.90 on Thursday. The company recently posted upbeat quarterly sales.

Gainers: Enservco (ENSV) +29%. Arcadia Biosciences (RKDA) +24%. CVR Energy (CVI) +13%. Losers: New Fortress Energy(NFE) -11%. Azure Power Global (AZRE) -10%. Danimer Scientific (DNMR) -10%.

Gainers: AgriFORCE Growing Systems AGRI +159%.Arcadia Biosciences (RKDA) +44%.CEA Industries CEAD +32%.Enservco ENSV +30%.Ebix EBIX +27%.Pop Culture Group (CPOP) +26%.Natera…

4 Hot Penny Stocks To Buy According To Analysts. The post 4 Penny Stocks With Huge Potential According To Analyst Forecasts appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt

4 Hot Penny Stocks To Buy According To Analysts. The post 4 Penny Stocks With Huge Potential According To Analyst Forecasts appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt

Gainers: Indonesia Energy Corporation (INDO) +65%. Ferroglobe (GSM) +20%. Losers: PermRock Royalty Trust (PRT) -13%.

Arcadia Biosciences (RKDA) appointed consumer veteran Stan Jacot as CEO effective Feb. 2

Arcadia Biosciences Inc (RKDA) shares closed today 11.8% higher than it did at the end of yesterday. The stock is currently up 9.6% year-to-date, down 58.2% over the past 12 months, and down 93.7% over the past five years. Today, the Dow Jones Industrial Average fell 0.0%, and the S&P 500 fell 0.4%. Trading Activity Shares traded as high as $1.65 and as low as $1.00 this week.Shares closed 82.2% below its 52-week high and 17.3% above its 52-week low.Trading volume this week was 77.8% lower than the 10-day average and 42.5% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.4. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Materials industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -357.7% The company's stock price performance over the past 12 months lags the peer average by 264.4% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -9.0% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Top penny stocks to buy according to analysts right now. The post 4 Top Penny Stocks Analysts Say To Buy Now & Targets Up To 408% appeared first on Penny Stocks to Buy, Picks, News and Information | P

Arcadia Biosciences Inc (RKDA) shares closed 1.4% lower than its previous 52 week low, giving the company a market cap of $31M. The stock is currently down 44.3% year-to-date, down 57.6% over the past 12 months, and down 93.9% over the past five years. This week, the Dow Jones Industrial Average fell 1.9%, and the S&P 500 fell 2.1%. Trading Activity Trading volume this week was 26.8% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -5900.4% The company's stock price performance over the past 12 months lags the peer average by -522.3% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 17.2% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Wall Street brokerages forecast that Arcadia Biosciences, Inc. (NASDAQ:RKDA) will announce sales of $3.68 million for the current quarter, according to Zacks. Two analysts have provided estimates for Arcadia Biosciences earnings. The lowest sales estimate is $3.63 million and the highest is $3.72 million. Arcadia Biosciences reported sales of $7.13 million in the same quarter []

Arcadia Biosciences (NASDAQ:RKDA) posted its quarterly earnings results on Sunday. The basic materials company reported ($0.10) earnings per share for the quarter, topping the Thomson Reuters consensus estimate of ($0.23) by $0.13, Fidelity Earnings reports. Arcadia Biosciences had a negative return on equity of 44.75% and a net margin of 3.98%. During the same quarter []

Arcadia Biosciences (NASDAQ:RKDA) announced its quarterly earnings data on Sunday. The basic materials company reported ($0.10) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.13, Fidelity Earnings reports. Arcadia Biosciences had a negative return on equity of 44.75% and a net margin of 3.98%. During the same quarter last year, the company []